Clinical Trial Update: Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the safety of subcutaneous testosterone enanthate in adult male hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• testosterone enanthate (subcutaneous) (testosterone enanthate)

Snippet

Sponsor: Antares Pharma Inc. | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2018-02-26